Answers are grounded in this paper and cite their sources.
In this study, we encapsulated W18O49 NPs with PEG-PCL NPs (W18O49@PEG-PCL NPs). The PEG-PCL NPs enhance the biocompatibility, stability and internalization of the W18O49 NPs in cells. Retained for a long time, these W18O49@PEG-PCL NPs possess excellent CT efficiency and superior PTT potency, which confer them with the potential to play an active role in future clinical trials.
No takes yet. Share an insight, caveat, or question.
Mu et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: